Articles dans des revues avec comité de lecture (110)
  1. 44. Abou-Khalil, B., & Depondt, C. (2018). Genome-wide mega-analysis identifies 16 loci and highlights diverse biological mechanisms in the common epilepsies. Nature communications, 9(1), 5269. doi:10.1038/s41467-018-07524-z
  2. 45. Reetz, K., Depondt, C., et al. (2018). Nonataxia symptoms in Friedreich Ataxia: Report from the Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS). Neurology.
  3. 46. May, P., Depondt, C., et al. (2018). Rare coding variants in genes encoding GABAA receptors in genetic generalised epilepsies: an exome-based case-control study. The Lancet. Neurology.
  4. 47. Sen, A., Dugan, P., Perucca, P., Costello, D., Choi, H., Bazil, C. C., Radtke, R., Andrade, D., Depondt, C., Heavin, S., Adcock, J., Pickrell, W. O., McGinty, R., Nascimento, F., Smith, P., Rees, M. M., Kwan, P., O'Brien, T. J., Goldstein, D., & Delanty, N. (2018). The phenotype of bilateral hippocampal sclerosis and its management in “real life” clinical settings. Epilepsia, 59(7), 1410-1420. doi:10.1111/epi.14436
  5. 48. Anttila, V., Depondt, C., et al. (2018). Analysis of shared heritability in common disorders of the brain. Science, 360(6395).
  6. 49. Melac, A. T., Mariotti, C., Pierucci, A. F., Giunti, P., Arpa, J., Boesch, S., Klopstock, T., vom Hagen, J. M., Klockgether, T., Bürk, K., Schulz, J. B., Reetz, K., Pandolfo, M., Dürr, A., du Montcel, S. T., Panzeri, M., Parkinson, M. M., Sanz-Gallego, I., Nachbauer, W., Karin, I., Depondt, C., Schoels, L., Giordano, I. A., Nanetti, L., Castaldo, A., & Eigentler, A. (2018). Friedreich and dominant ataxias: Quantitative differences in cerebellar dysfunction measurements. Journal of neurology, neurosurgery and psychiatry, 89(6), 559-565. doi:10.1136/jnnp-2017-316964
  7. 50. Whelan, C. C., Absil, J., David, P., Depondt, C., et al. (2018). Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study. Brain, 141(2), 391-408. doi:10.1093/brain/awx341
  8. 51. McCormack, M., & Depondt, C. (2018). Genetic variation in CFH predicts phenytoin-induced maculopapular exanthema in European-descent patients. Neurology, 91(16), 765. doi:10.1212/WNL.0000000000004853
  9. 52. Androsova, G., Borghei, M., Depondt, C., Brodie, M. J., Chinthapalli, K., de Haan, G. J., Doherty, C. P., Gudmundsson, L. L., Heavin, S., Ingason, A., Johnson, M., Kennedy, C., Krenn, M., McCormack, M., O'Brien, T. J., Pandolfo, M., Pataraia, E., Petrovski, S., Rau, S., Sargsyan, N., Slattery, L., Stefánsson, K., Stern, W., Tostevin, A., Willis, J., Zimprich, F., et al. (2017). Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia, 58(10), 1734-1741. doi:10.1111/epi.13871
  10. 53. Fogang, Y., Legros, B., Depondt, C., Mavroudakis, N., & Gaspard, N. (2017). Rendement de l'EEG intermittent répété pour la detection des crises chez les patients adultes en réanimation. Neurophysiologie clinique, 47(1), 5-12. doi:10.1016/j.neucli.2016.09.001
  11. 54. Linnemann, C., Rola, R., Klockgether, T., García, A., Mutlu, G., Schöls, L., Tezenas du Montcel, S., Rakowicz, M., Schmitz-Hübsch, T., Szymanski, S., Berciano, J., van de Warrenburg, B. P. C., Pedersen, K., & Depondt, C. (2016). Peripheral Neuropathy in Spinocerebellar Ataxia Type 1, 2, 3, and 6. Cerebellum, 15(2), 165-173. doi:10.1007/s12311-015-0684-6
  12. 55. Bellante, F., Legros, B., Depondt, C., Creteur, J., Taccone, F., & Gaspard, N. (2016). Midazolam and thiopental for the treatment of refractory status epilepticus: a retrospective comparison of efficacy and safety. Journal of neurology, 263(4), 799-806. doi:10.1007/s00415-016-8074-7
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 Suivant >>